perfluorocarbon


Also found in: Dictionary, Thesaurus, Encyclopedia, Wikipedia.

perfluorocarbon

 [per-floor´o-kahr″bon]
any of various substances chemically related to a hydrocarbons but with the hydrogen atoms replaced by fluorine atoms. In gaseous form they cause environmental damage by collecting in the upper atmosphere; in liquid form, some are used in partial liquid ventilation.

perfluorocarbon

[pərfloo͡r′ōkär′bən]
any of a group of chemicals with limited capacity for transporting oxygen through the circulatory system. They can be used for certain blood substitute purposes, regardless of the blood type of the patient. They are stable at room temperatures, have a pH of 7.4, and are free of infectious pathogens. Also called artificial blood or blood substitute.

perfluorocarbon

(pĕr-floor″-ă-kahr′ bŭn, -floo″ă-rō-)
A class of solvent molecules that can carry nonpolar gases, such as oxygen, nitrogen, and carbon dioxide. They have been used experimentally in transfusion medicine and in some ophthalmic surgeries. Perfluorocarbons are also used as blood gas controls when prepared in buffered solutions equilibrated with CO2 and O2.
Mentioned in ?
References in periodicals archive ?
The company has developed a perfluorocarbon (PFC) therapeutic oxygen carrier and liquid ventilation product (Oxycyte(TM)) and has out-licensed an implantable glucose sensor.
Oxygen Biotherapeutics, Inc. Outlines Plans for New Products During Investor Conference Presentation
Oxycyte is a sterile, milky white, sub-micron (median diameter of 200-250 nm) perfluorocarbon (PFC) emulsion intended for intravenous injection.
Oxygen Biotherapeutics Enters License and Supply Agreement for Dermacyte[R] Products with the Cosmetics Division of Valor SA
Oxycyte is an odorless, milky white emulsion consisting of a perfluorocarbon, disodium, water, egg yolk phospholipids and a few other ingredients in very small amounts.
Oxygen Biotherapeutics' Update on U.S. Army-Funded Preclinical Studies Designed to Support the Safety Profile of Oxycyte PFC Emulsion Currently in Clinical Trials Overseas for Traumatic Brain Injury
He then placed six of the animals on typical gas ventilators and six on ventilators that circulated perfluorocarbon through the lungs.
Healing touch of liquid breath
The concept of utilizing our perfluorocarbon emulsion as a way to bolster the delivery of oxygen to wounds from inside the body is new and fascinating.
Oxygen Biotherapeutics Signs Cooperative Research and Development Agreement with U.S. Navy to Investigate the Use of Oxycyte PFC Emulsion as an Adjunctive Treatment of Complex Infected Wounds and Related Injuries
The Company is also developing non-medical applications for its perfluorocarbon (PFC) product.
Sanguine Announces Positive Results of Stability Study
MBA, chairman and chief executive officer of Sanguine, stated, "It is the function of our Scientific Advisory Board to investigate and develop non-medical applications for our perfluorocarbon product.
Sanguine to Partner With Virginia Commonwealth University to Study Use of PFCs in Fuel Cell Technology
The two-day conference was attended by experts in perfluorocarbon technology, environmental protection, fuel cell technology and other industries that could provide opportunities for PFCs.
Sanguine Announces Results of First Scientific Advisory Board Meeting -- Refines Non-Medical Applications For Pher-O2 --
SONUS Pharmaceuticals and SUNY/UB have been collaborating in the research and development of a blood substitute product for oxygen delivery based on SONUS' proprietary perfluorocarbon emulsion technology.
SONUS Pharmaceuticals Blood Substitute Product Demonstrates Efficiency As Oxygen Carrier
The laboratory investigation suggests that administration of a perfluorocarbon with the characteristics and performance of Oxycyte combined with 100% oxygen therapy can reverse tissue oxygen deficit and holds promise for reducing ischemic injury," said Bruce D.
Published Study Shows Oxycyte Successfully Reduces Oxygen Shortages in a Spinal Cord Injury Model
Bulletin Board: SYBD) today announced results of independent animal testing that indicate a breakthrough in the development of its oxygen-carrying perfluorocarbon (PFC) liquid ventilation product, Fluorovent(TM).
SYNTHETIC BLOOD INTERNATIONAL ANNOUNCES BREAKTHROUGH IN LIQUID VENTILATION RESEARCH
Van Liew's group points the way to exciting possibilities for therapeutic uses of our perfluorocarbon microbubbles to deliver oxygen to tissues which need it, as in high-blood-loss surgical procedures, chronic anemia, and traumatic injury.
SONUS PHARMACEUTICALS INITIATES RESEARCH IN THERAPEUTIC BLOOD SUBSTITUTES

Medical browser ?
Full browser ?